Skip to main content

Table 5 Result summary of the comparison analysis between Stage I HCC and Stage II or III HCCs (Figure 3 C and D)

From: Recurrent genetic alterations in hepatitis C-associated hepatocellular carcinoma detected by genomic microarray: a genetic, clinical and pathological correlation study

Region [hg19]

Cytoband location

Copy number

Region length (kb)

Stage I (freq. %)

Stages II-III (freq. %)

p-value

Number of genes

Sanger census cancer genes

chr7:13,933,308-14,289,034

p21.2

Gain

356

70

0

0.026

2

ETV1

chr7:54,910,410-55,228,621

p11.2

Gain

318

70

0

0.026

1

EGFR

chr7:61,750,617-159,138,663

q11.21-q36.3

Gain

97,388

60

0

0.044

757

SBDS, ELN, HIP1, AKAP9, CDK6, MET, SMO, CREB3L2, KIAA1549, BRAF, EZH2, MLL3

chr7:115,832,560-116,493,846

q31.2

Gain

661

70

0

0.026

4

MET